(2S,5S)-1-Hydroxy-2,5-diphenylphospholane 1-oxide, 98%, 1g

2-Methylthiophene, 98.0%, 1g

Allyl Glycidyl Ether>99.0%(GC)25mL

4-(3-bromo-4-methoxyphenyl)-1,3-thiazol-2-amine, 95.0%, 1g

Methyl 2-hydroxy-1-naphthoate, 95.0%, 25g

Closing caps, Gesch. front, Ø 38 mm 250 pcs

[1-(cyclobutylmethyl)-1H-1,2,3-triazol-4-yl]methanol, 95.0%, 500mg

Nitrocyclohexane, 95.0%, 250mg

6-Fluoro-4-oxo-4H-chromene-3-carbaldehyde, 95.0%, 25g

2-Fluoro-6-(2,2,2-trifluoroethoxy)benzonitrile, 97.0%, 25g

TERT-BUTYL 3-HYDROXY-3-PHENYLAZETIDINE-1-CARBOXYLATE, 95.0%, 100mg

3,4-DIMETHOXY-N-(4-(3-NITROPHENYL)THIAZOL-2-YL)BENZENESULFONAMIDE, 95%, 100mg

Methyl 4-{[(tert-butoxy)carbonyl]amino}piperidine-4-carboxylate hydrochloride, 97%, 250mg